Two Months In: Turning Down a €500K Investment

In just two months, MyZenCheck has sparked significant interest in the digital wellness space. We were recently offered €500,000 for a 40% stake in our company. It’s a milestone—but one we chose not to accept.

Why?

Because that valuation only reflects where we are now—not where we’re going.


Exponential Momentum: From 5K to 10K Users in Two Weeks

In the last 14 days alone, we’ve doubled our user base—adding 5,000 new clients, the same number it took us six weeks to acquire after launch. This steep curve in user growth isn’t coincidental—it’s the result of a clearly defined product-market fit and strategic user experience optimization.

Each new client validates our core technology: a self-assessment app combining AI-powered tongue analysis with holistic health insights grounded in Traditional Chinese Medicine (TCM).


Positive Cash Flow and Strong Demand Signal

We’re in the rare position of having positive cash flow this early on. Investor interest isn’t limited to one offer—we’ve been approached by several international partners, including invitations to pitch in Dubai, with active online discussions in progress.

But our focus remains: long-term value over early exits.


Why We’re Holding Out for Q4

Gabriela Sikorova, Co-founder of MyZenCheck, put it clearly:

We believe that by Q4 2025, our app will not only reach 95% scan accuracy but will also scale to include 12 autonomous AI agents working in harmony to decode tongue indicators of internal health.

This leap in precision and complexity will multiply our market valuation—by at least 5x.

gabriela sikorova founder of myzencheck
gabriela sikorova founder of myzencheck

What Drives Us Forward

It’s not just technology or growth metrics—it’s the positive feedback from our users. People are discovering a new way to self-monitor stress, energy, and health using ancient wisdom and modern innovation.

This is more than a product. It’s a wellness revolution powered by AI.


External Reference

For deeper insights into how tongue diagnosis is rooted in Traditional Chinese Medicine, see NIH’s study on tongue inspection and AI in health diagnostics.

Why did MyZenCheck decline a €500K investment?

The offer undervalued our projected growth and potential. With user numbers doubling in two weeks, we expect our value to increase at least fivefold by Q4.

When will you accept investors?

We’re targeting a strategic investor entry in Q4 2025 once key development milestones are met.

What’s next for MyZenCheck?

Expansion of our AI capabilities, scaling to 12 autonomous agents, deeper global partnerships, and continuous refinement of the user experience.

Leave a Reply

Your email address will not be published. Required fields are marked *